Do topical nasal decongestants affect polyps?

Acta Oto-Laryngologica

Volumn 126, Issue 3, 2006, Pages 288-290

  Johansson, Leif ^a   Öberg, Dan ^a   Melén, Ingemar ^a   Bende, Mats ^a  

^a CENTRAL HOSPITAL   (Sweden)

Author keywords

Decongestants; Endoscopy; Nasal polyps; Scoring system

Indexed keywords

ADRENALIN; DECONGESTIVE AGENT; NAPHAZOLINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; HUMAN; MALE; NOSE CAVITY; NOSE POLYP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TUMOR DIAGNOSIS; TUMOR VOLUME;

ADMINISTRATION, INTRANASAL; ADULT; AGED; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY; EPINEPHRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAPHAZOLINE; NASAL DECONGESTANTS; NASAL POLYPS; PROBABILITY; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 32944454662     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480500388877     Document Type: Article

References (16)

1. Mygind N. Nasal polyps. In: Mygind N, editor. Essential allergy. An illustrated text for students and specialists. Oxford, UK: Blackwell Scientific; 1986. p. 324-8.
2. Settipane GA. Incidence of nasal polyps. In: Tos M, Thomsen J, Balle V, editors. Rhinology. A state of the art. Amsterdam. The Netherlands: Kugler Publications; 1995. p. 481-4.
3. Johansson L, Brämerson A, Holmberg K, Melén I, Åkerlund A, Bende M. Clinical relevance of nasal polyps in individuals recruited from a general population-based study. Acta Otolaryngol 2004;124:77-81.
4. Larsen K. The clinical relationship of nasal polyps to asthma. Allergy Asthma Proc 1996;107:243-9.
5. Rasp G, Kramer MF, Ostertag P, Kastenbauer E. Ein neues System zur Einteilung der Siebbeinpolyposis. Laryngorhinootologie 2000;79:266-72.
6. Lund VJ, Kennedy DW. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 1997;117:35-40.
7. Elbez M, De Pressigny M, Halimi Ph, Aidan D, Bonfils P, Trotoux J. Does the use of nasal vasoconstrictor agents change tomodensitometric images of nasosinusal polyposis? Ann Otolaryngol Chir Cervociofac 1993;110:277-80 (in French).
8. Johansson L, Åkerlund A, Holmberg K, Melén I, Stierna P, Bende M. Evaluation of methods for endoscopic staging of nasal polyposis. Acta Otolaryngol 2000;120:72-6.
9. Johansson L, Holmberg K, Melén I, Stierna P, Bende M. The sensitivity of a new grading system for studying nasal polyps with potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide). Acta Otolaryngol 2002;122:49-53.
10. Cauna N. The fine structures of the arteriovenous anastomosis and its nerve supply in the human nasal respiratory mucosa. Anat Rec 1970;168:9-22.
11. Cauna N, Hinder K, Manzethi G, Swanson E. Fine structure of nasal polyps. Ann Otol Rhinol Laryngol 1974;81:436-42.
12. Bende M, Flisberg K. Blood flow in nasal polyps. J Laryngol Otol 1983;99:167-9.
13. Andersson KE, Bende M. Adrenoceptors in the control of human nasal mucosal blood flow. Ann Otol Rhinol Laryngol 1984;93:179-82.
14. Bende M, Löth S. Vascular effects of topical oxymetazoline on human nasal mucosa. J Laryngol Otol 1986;100:285-8.
15. Bende M. The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngol (Stockh) 1983;96:523-7.
16. Graf P, Juto JE. Decongestion effect and rebound swelling of the nasal mucosa during four-week use of oxymetazoline. ORL J Otorhinolaryngol Relat Spec 1994;56:31-4.